Marleen Van Kerckhove, Sep 30, 2013
The EC’s 2009 Sector Inquiry Report on certain practices in the European pharmaceutical sector described in considerable detail the practice and nature of settlement agreements between originator companies and generic companies in the European Union in the period 2000-2008. The Report did not intend to lay down guidance on the compatibility of these agreements with EU competition law. However, it does refer to the FTC having found some of these agreemen
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.145.186.173
Please verify email or join us to access premium content!